333. Hutchinson-Gilford syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 8 / Drugs : 8 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 6
Hutchinson-Gilford syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 333 | Hutchinson-Gilford syndrome |
| 113 | Muscular dystrophy |
| 34 | Neurofibromatosis |
| 66 | IgA nephropathy |
| 93 | Primary biliary cholangitis |
| 271 | Ankylosing spondylitis |
| 299 | Cystic fibrosis |
| 49 | Systemic lupus erythematosus |
| 96 | Crohn disease |
| 46 | Malignant rheumatoid arthritis |
| 6 | Parkinson disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |